Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BCYC stock hub

Bicycle Therapeutics plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BCYCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
335.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
BCYC
In the news

Latest news · BCYC

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROEn/a
P25 -105.6P50 -46.5P75 -3.1
ROIC-21.6
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BCYC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
168
Groups with data
10
Currency
USD
Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001761612
Company name
Bicycle Therapeutics plc
Country
United Kingdom
Country code
US
Cusip
088786108
Employees
288
Employees Change
-17%
Employees Change Percent
-5.57
Enterprise value
$-276M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2019-05-23
Isin
US0887861088
Last refreshed
2026-05-10
Market cap
$335.3M
Market cap category
Small-Cap
Price
$4.81
Price currency
USD
Rev Per Employee
220,472.22x
Sector
Healthcare
Sic
2834
Symbol
BCYC
Website
https://www.bicycletherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-65.32%
P/B ratio
0.55x
P/S ratio
5.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross margin
-260.78%
Gross Profit
$-165.6M
Net Income
$-219M
Net Income Growth Years
0%
Pretax Margin
-342.71%
Profit Per Employee
$-760,490
Roa5y
-17.54
Roe5y
-36.67
ROIC
-21.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
-38.2%
Cagr3y
-39.51%
Cagr5y
-31.44%
EPS Growth Quarters
2
EPS Growth Years
0
Revenue Growth
146.86x
Revenue Growth Q
-91.11x
Revenue Growth Years
5x
Revenue Growth3 Y
60.01x
Revenue Growth5 Y
41.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
$628.1M
Debt
$16.9M
Debt Equity
$0.03
Equity
$610M
Interest Coverage
-1,173.1
Net Cash
$611.3M
Net Cash By Market Cap
$182
Net Cash Growth
-22.1%
Net Debt Equity
$-1
Tangible Book Value
$610M
Tangible Book Value Per Share
$8.79
WACC
12.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-6.99%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-38.17%
200-day SMA
6.56
3Y total return
-77.87%
50-day SMA
4.95
50-day SMA vs 200-day SMA
50under200
5Y total return
-84.85%
All Time High
62.08
All Time High Change
-92.25%
All Time High Date
2021-11-15
All Time Low
4.24
All Time Low Change
13.44%
All Time Low Date
2026-03-27
ATR
0.25
Beta
1.56
Beta1y
1.62
Beta2y
1.76
Ch YTD
-32.06
High
4.92
High52
9.36
High52 Date
2025-06-11
High52ch
-48.61%
Low
4.79
Low52
4.24
Low52 Date
2026-03-27
Low52ch
13.44%
Ma50ch
-2.89%
Price vs 200-day SMA
-26.63%
RSI
46.31
RSI Monthly
31.31
RSI Weekly
38.04
Sharpe ratio
-0.69x
Sortino ratio
-0.84
Total Return
-6.99%
Tr YTD
-32.06
Tr1m
-1.84%
Tr1w
0.21%
Tr3m
-15.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
8
Analyst Count Top
4
Analyst Price Target Top
$17.75
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$-0.62
Earnings Revenue Estimate
7,619,280x
Earnings Revenue Estimate Growth
-23.63x
Operating Income
$-238.1M
Operating margin
-375.1
Price target
$13.75
Price Target Change
$186
Price Target Change Top
$269

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Shares Insiders
1.8%
Shares Institutions
34.83%
Shares Out
69,707,026
Shares Qo Q
0.46%
Shares Yo Y
6.99%
Short Ratio
4.45
Short Shares
6.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Average Volume
416,436.8x
Bv Per Share
8.79
Ch1m
-1.84
Ch1w
0.21
Ch1y
-38.17
Ch3m
-15.02
Ch3y
-77.87
Ch5y
-84.85
Ch6m
-25.31
Change
-1.64%
Change From Open
-1.43
Close
4.89
Days Gap
-0.2
Depreciation Amortization
6,393,500
Dollar Volume
1,682,475.5
Earnings Date
2026-04-30
Earnings Time
bmo
EBIT
$-238.1M
EBITDA
$-231.7M
EPS
$-3.16
F Score
1
Fiscal Year End
December
Founded
2,009
Income Tax
$1.4M
Ipr
-65.64
Iprfo
-64.02
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-03-17
Ma150
6.25
Ma150ch
-23.03%
Ma20
4.96
Ma20ch
-2.93%
Next Earnings Date
2026-08-07
Open
4.88
Optionable
Yes
Position In Range
15.62
Post Close
4.81
Postmarket Change Percent
-0.42
Postmarket Price
$4.79
Price Date
2026-05-08
Ptbv Ratio
0.55
Relative Volume
0.84x
Revenue
63,496,000x
Tax By Revenue
2.22x
Tr6m
-25.31%
Volume
349,787
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BCYC pay a dividend?

Capital-return profile for this ticker.

Performance

BCYC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-38.2%
S&P 500 1Y: n/a
3Y total return
-77.9%
S&P 500 3Y: n/a
5Y total return
-84.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BCYC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+34.8%
Share of float held by funds and institutions
Insider ownership
+1.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.5 days to cover
Y/Y dilution
+7.0%
Negative means the company is buying back shares.
Technical

BCYC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.3
Neutral momentum band
Price vs 200-day MA
-26.6%
50/200-day relationship not available
Beta (5Y)
1.56
More volatile than the market
Sharpe ratio
-0.69
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BCYC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BCYC stock rating?

Bicycle Therapeutics plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BCYC analysis?

The full report lives at /stocks/BCYC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BCYC?

The latest report frames BCYC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BCYC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.